Ame Company for Medical Supplies (9527)
Market Closed
14 Dec, 12:00
XSAU XSAU Primary ﷼
101. 40
+1.4
+1.4%
﷼
749M Market Cap
11.3 P/E Ratio
8% Div Yield
9,171 Volume
0 Eps
﷼ 100
Previous Close Day Range
99.65 104.5
Year Range
95 149.8
Want to track 9527 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
9527 closed today higher at ﷼101.4, an increase of 1.4% from yesterday's close, completing a monthly decrease of -0.39% or ﷼0.4. Over the past 12 months, 9527 stock lost -18.88%.
9527 pays dividends to its shareholders, with the most recent payment made on Jul 06, 2023.
The last earnings report, released on Jun 17, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSAU (SAR).
9527 Chart
Similar
Ame Company for Medical Supplies (9527) FAQ
What is the stock price today?
The current price is ﷼101.40.
On which exchange is it traded?
Ame Company for Medical Supplies is listed on XSAU.
What is its stock symbol?
The ticker symbol is 9527.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 8%.
What is its market cap?
As of today, the market cap is 749M.
Has Ame Company for Medical Supplies ever had a stock split?
No, there has never been a stock split.
Ame Company for Medical Supplies Profile
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | - CEO | XSAU Exchange | SA15GGP4KRH1 ISIN |
| Saudi Arabia Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Ame Company For Medical Supplies, founded in 2005, is a prominent distributor and marketer of medical supplies specifically tailored for the aesthetic market in Saudi Arabia. Based in Jeddah, the company has carved out a niche for itself by offering an extensive range of high-quality products and services designed to meet the evolving needs of the healthcare and cosmetic industries within the region. With a focus on innovation, Ame Company has become a key player in enhancing the standards of aesthetic treatments available to professionals and patients alike.
Products and Services
- Teoxane: A cutting-edge collection of injectable hyaluronic acid-based dermal fillers, Teoxane is specifically formulated to address and treat wrinkles on the face and neck. It stands out for its ability to offer immediate and lasting results, enhancing skin hydration and firmness.
- Medical Laser Systems and New Therapies: Ame Company provides advanced medical laser systems that are at the forefront of aesthetic and dermatological treatments. These systems offer solutions for a range of skin conditions and aesthetic concerns, showcasing the company's commitment to bringing innovative therapies to the market.
- Botulinum Products: The company's portfolio includes botulinum toxin products, which are used in the cosmetic industry to reduce the appearance of facial wrinkles and lines. These products are highly sought after for their effectiveness in non-surgical facial rejuvenation.
- Magellan: This autologous concentration system is designed to deliver concentrated platelets and cells at the point of care. Magellan represents a leap forward in regenerative medicine, offering potential in various therapeutic applications, including wound care and soft tissue healing.
- MINT: Standing for Minimally Invasive Nonsurgical Thread, MINT is an absorbable polydioxanone barbed suture. It is indicated for use in soft tissue approximation, with applications in aesthetic surgery such as facelifts and neck lifts. MINT sutures represent a non-surgical alternative to more invasive procedures, providing aestheticians and patients with innovative options for cosmetic enhancement.
Contact Information
Address: King Fahad Road 8088
Phone: 966 12 275 0203
Website: https://www.ame.med.sa
2025 © Marketlog. All Rights Reserved.
